Form: S-8

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

August 25, 2023

Documents

 

Exhibit 107

Calculation of Filing Fees Table

 

Form S-8

(Form Type)

 

Acasti Pharma Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities

 

Security Type

Security Class Title

Fee Calculation Rule

Amount Registered

Proposed Maximum Offering Price Per Unit (2)

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Equity

Common Shares, no par value per share

Rule 457(c) and Rule 457(h)

1,483,140
shares (1)

$2.07

$3,070,099.80

$110.20 per million

$338.32

Total Offering Amounts

 

 

$3,070,099.80

 

$338.32

Total Fee Offsets

 

 

 

 

$0

Net Fee Due

 

 

 

 

$338.32

 

(1) Represents 1,483,140 common shares reserved for issuance under the Acasti Pharma Inc. Stock Option Plan, as amended, and the Acasti Pharma Inc. Equity Incentive Plan, as amended (together the “Plans”). Pursuant to Rule 416 of the Securities Act of 1933, as amended (the “Securities Act”) there are also registered hereunder such indeterminate number of additional shares as may become available for issuance pursuant to the Plans as a result of the antidilution provisions contained therein, including stock splits and other similar transactions.

 

(2) Estimated in accordance with paragraphs (c) and (h) of Rule 457 of the Securities Act, based upon the average of the daily high and low prices of shares of the registrant’s common stock on August 24, 2023, as reported on the Nasdaq Capital Market.

MACROBUTTON DocID \\4138-5887-4185 v1